Key facts
- This page summarizes Lance E. Thibault's Form 3 filing for Finch Therapeutics Group, Inc. (FNCH).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 May 2023, 16:05.
Lance E. Thibault - 16 May 2023 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- FNCH
- Reported as of
- 16 May 2023
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 16 May 2023, 16:05:22 UTC
- Prior SEC filing
- 03 Feb 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Matthew P. Blischak, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Lance E. Thibault filed Form 3 for Finch Therapeutics Group, Inc. (FNCH) on 16 May 2023.
Change
- Previous filing in this sequence was filed on 03 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Additional SEC filing notes
Filing notes and footnotes
Ownership status
The filing reports no beneficially owned securities.
SEC remarks
Exhibit List - Exhibit 24 - Power of Attorney